
Michael Foley
51 posts

Michael Foley
@MikeFoley89
Cardiology Registrar | MRC Clinical Research Training Fellow | Imperial College London


















Watch This Week's Episode of OPCI Journal Club: “ORBITA-STAR Trial and the ORBITA II Symptoms Analysis” presented by @rallamee @rajkumar_chris and @FloSimader. Joined by panelists @djc795 @JWMoses @ESHLOF and Dr. Lawrence Garcia. opci.live/journal-club/ #cardiotwitter
















Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective tctmd.com/news/mechanism…

2. NovPod is a light-hearted informative intro to the specialty and an audio companion to the Novice Guide. Brought to you by creators and hosts @DoreEoin and Dr Duncan Kemp. bit.ly/43QpaFj

Have you already metabolized the outcomes of ORBITA 2? Next stop in the ORBITA program is called ORBITA-COSMIC. The coronary sinus Reducer (CSR) is an hourglass-shaped device which creates an artificial stenosis in the coronary sinus. The ORBITA-COSMIC trial is a randomized, placebo-controlled, double-blind trial investigating the efficacy of the CSR on quantified myocardial perfusion and stable angina. Here is the study rationale and design paper. eurointervention.pcronline.com/article/a-doub…



So proud to be part of this incredible team and experience #ORBITA2 #AHA23